Pyxis Oncology, Inc.
PYXS
Revenue
16.15M
▲16.15M∞%
-Assets
195.31M
▼-13.08M▼-6.28%
3 Months ChangeLiabilities
41.63M
▲3.04M▲7.87%
3 Months ChangeFree Cash Flow
-20.95M
▲10.30M▲32.96%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-23
Form 8-K
ID: 0000950170-24-116698
2024-08-14
Form 10-Q
ID: 0000950170-24-097073
2024-08-14
Form 8-K
ID: 0000950170-24-097054
2024-06-12
Form 8-K
ID: 0000950170-24-072467
2024-06-10
Form 8-K
ID: 0001193125-24-157911
2024-05-14
Form 10-Q
ID: 0000950170-24-059099
2024-05-14
Form 8-K
ID: 0000950170-24-059093
2024-03-27
Form 8-K
ID: 0000950170-24-037176
2024-03-27
Form 8-K
ID: 0000950170-24-036822
2024-03-21
Form 8-K
ID: 0000950170-24-034427